LYONS GARY A sold TVTX
April 14, 2026 · Form 4 insider transaction
LYONS GARY A sold 8,000 shares of Travere Therapeutics, Inc. at $41.07 per share, a transaction worth $328.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,000
Price
$41.07
Total value
$328.6K
InsiderLYONS GARY A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 14, 2026
Filing dateApril 16, 2026
Shares owned after57,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on November 11, 2025 meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and consists of the sale of shares underlying a stock option granted to the Reporting Person with an expiration date of May 18, 2026.